Literature DB >> 6787063

Effects of thyrotropin-releasing hormone and metoclopramide in patients with phenothiazine-induced hyperprolactinemia.

H V Lankford, W G Blackard, D F Gardner, H S Tucker.   

Abstract

TRH and metoclopramide tests were performed in 10 female patients with presumed phenothiazine-induced hyperprolactinemia to define the serum PRL response to these agents. Our results show that the serum PRL response to metoclopramide is blunted in most patients with phenothiazine-induced hyperprolactinemia, and the serum PRL response to TRH is exaggerated in most patients during and 3 weeks after stopping phenothiazines.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6787063     DOI： 10.1210/jcem-53-1-109

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


  3 in total

1.  Flunarizine increases PRL secretion in normal and in migraineous women.

Authors:  U Bonuccelli; P Piccini; A M Paoletti; A Nuti; A Colzi; G B Melis; A Muratorio
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

2.  The inability of dynamic tests of prolactin and TSH secretion to differentiate between tumorous and non-tumorous hyperprolactinemia.

Authors:  R W Prescott; D G Johnston; P K Taylor; J Haigh; D R Weightman; K Hall; D B Cook
Journal:  J Endocrinol Invest       Date:  1985-02       Impact factor: 4.256

3.  Responses of prolactin and growth hormone to L-tryptophan infusion: effects in normal subjects and schizophrenic patients receiving neuroleptics.

Authors:  P J Cowen; H Gadhvi; B Gosden; T Kolakowska
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.